Vasoactive intestinal peptide and cytokines enhance stem cell factor production from epidermal keratinocytes DJM-1

Journal of Investigative Dermatology

Volumn 119, Issue 5, 2002, Pages 1183-1188

  Kakurai, Maki ^a   Fujita, Nobuya ^a   Kiyosawa, Tomoharu ^a,c   Inoue, Tae ^b   Ishibashi, Shun ^a   Furukawa, Yusuke ^a   Demitsu, Toshio ^a   Nakagawa, Hidemi ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b AKITA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

Author keywords

Atopic dermatitis; Dermatoses; Neuropeptide; Skin

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 13; INTERLEUKIN 4; STEM CELL FACTOR; TUMOR NECROSIS FACTOR ALPHA; VASOACTIVE INTESTINAL POLYPEPTIDE;

ARTICLE; ATOPIC DERMATITIS; CELL LEVEL; CELL LINE; CELL MEMBRANE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOPLASM; DERMIS; EPIDERMIS; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; KERATINOCYTE; MOLECULAR SIZE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; SKIN FIBROBLAST;

EID: 18744374591     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1747.2002.19506.x     Document Type: Article

References (35)

1. Anand P, Springall R, Blank MA, Sellu D, Polak JM, Bloom SR: Neuropeptides in skin disease increased VIP in eczema and psoriasis but not axillary hyperhidrosis. Br J Dermatol 124:547-549, 1991
2. Bellinger DL, Lorton D, Brouxhon S, Felten S, Felten DL: The significance of vasoactive intestinal polypeptide (VIP) in immunomodulation. Adv Neuroimmunol 6:5-27, 1996
3. Bjorklund H, Dalsgaard CJ, Jonsson CE, Hermansson A: Sensory and autonomic innervation of non-hairy and hairy human skin. An immunohistochemical study. Cell Tissue Res 243:51-57, 1986
4. Dastych J, Metcalfe DD: Stem cell factor induces mast cell adhesion to fibronectin. J Immunol 152:213-219, 1994
5. Funasaka Y, Boulton T, Cobb M, et al: c-Kit-kinase induces a cascade of protein tyrosine phosphorylation in normal human melanocytes in response to mast cell growth factor and stimulates mitogen-activated protein kinase but is down-regulated in melanomas. Mol Biol Cell 3:197-209, 1992
6. Giannetti A, Fantini F, Cimitan A, Pincelli C: Vasoactive intestinal polypeptide and substance P in the pathogenesis of atopic dermatitis. Acta Derm Venereol Stockh Suppl 176:90-92, 1992
7. Grabbe J, Welker P, Rosenbach T, et al: Release of stem cell factor from a human keratinocyte line, HaCaT, is increased in differentiating versus proliferating cells. J Invest Dermatol 107:219-224, 1996
8. Hartman M, Piliponsky AM, Temkin V, Levi-Schaffer F: Human peripheral blood eosinophils express stem cell factor. Blood 97:1086-1091, 2001
9. + allergen-specific T lymphocytes in atopic dermatitis lesional skin. J Invest Dermatol 97:389-394, 1991
10. Henz BM: SCF and c-kit in mastocytosis: A Pandora's box holding more theories than proven facts. J Invest Dermatol 110:186-187, 1998
11. Huang EJ, Nocka KH, Buck J, Besmer P: Differential expression and processing of two cell associated forms of the kit-ligand: KL-1 KL-2. Mol Biol Cell 3:349-362, 1992
12. Kakurai M, Fujita N, Murata S, Furukawa Y, Demitsu T, Nakagawa H: Vasoactive intestinal peptide regulates its receptor expression and functions of human keratinocytes via type I vasoactive intestinal peptide receptors. J Invest Dermatol 116:743-749, 2001
13. Kanbe T, Soma Y, Kawa Y, Kashima M, Mizoguchi M: Serum levels of soluble stem cell factor and soluble KIT are elevated in patients with atopic dermatitis and correlate with the disease severity. Br J Dermatol 144:1148-1153, 2001
14. ++ concentration. J Invest Dermatol 89:167-171, 1987
15. Kunisada T, Lu SZ, Yoshida H, et al: Murine cutaneous mastocytosis and epidermal melanocytosis induced by keratinocyte expression of transgenic stem cell factor. J Exp Med 187:1565-1573, 1998
16. Leung DYM: Pathogenesis of atopic dermatitis. J Allergy Clin Immunol 104:S99-S108, 1999
17. Longley BJ Jr, Morganroth GS, Tyrrell L, Ding TG, Anderson DM, Williams DE, Halaban R: Altered metabolism of mast-cell growth factor (c-kit ligand) in cutaneous mastocytosis. N Engl J Med 328:1302-1307, 1993
18. Lotti T, Hautmann G, Panconesi E: Neuropeptides in skin. J Am Acad Dermatol 33:482-496, 1995
19. Lowman MA, Benyon RC, Church MK: Characterization of neuropeptide-induced histamine release from human dispersed skin mast cells. Br J Pharmacol 95:121-130, 1988
20. Majumdar MK, Feng L, Medlock E, Toksoz D, Williams DA: Identification and mutation of primary and secondary proteolytic cleavage sites in murine stem cell factor cDNA yields biologically active, cell-associated protein. J Biol Chem 269:1237-1242, 1994
21. Meininger CJ, Yano H, Rottapel R, Bernstein A, Zsebo KM, Zetter BR: The c-kit receptor ligand functions as a mast cell chemoattractant. Blood 79:958-963, 1992
22. Mierke CT, Ballmaier M, Werner U, Manns MP, Welte K, Bischoff SC: Human endothelial cells regulate survival and proliferation of human mast cells. J Exp Med 192:801-811, 2000
23. Mitsui H, Furitsu T, Dvorak AM, et al: Development of human mast cells from umbilical cord blood cells by recombinant human and murine c-kit ligand. Proc Natl Acad Sci USA 90:735-739, 1993
24. Miyazawa K, Williams DA, Gotoh A, Nishimaki J, Broxmeyer HE, Toyama K: Membrane-bound Steel factor induces more persistent tyrosine kinase activation and longer life span of c-kit gene-encoded protein than its soluble form. Blood 85:641-649, 1995
25. Morita E, Lee DG, Sugiyama M, Yamamoto S: Expression of c-kit ligand in human keratinocytes. Arch Dermatol Res 286:273-277, 1994
26. Nilsson SFE, Mäepea O: Comparison of the vasodilatory effects of vasoactive intestinal polypeptide (VIP) and peptide-HI (PHI) in the rabbit and the cat. Acta Physiol Scand 129:17-26, 1987
27. Pincelli C, Fantini F, Massimi P, Girolomoni G, Seidenari S, Giannetti A: Neuropeptides in skin from patients with atopic dermatitis: An immunohistochemical study. Br J Dermatol 122:745-750, 1990
28. Pincelli C, Fantini F, Romualdi P, Lesa G, Giannetti A: Skin levels of vasoactive intestinal polypeptide in atopic dermatitis. Arch Dermatol Res 283:230-232, 1991
29. van Reijsen FC, Bruijnzeel-Koomen CA, Kalthoff FS, Maggi E, Romagnani S, Westland JK, Mudde GC: Skin-derived aeroallergen-specific T-cell clones of Th2 phenotype in patients with atopic dermatitis. J Allergy Clin Immunol 90:184-193, 1992
30. Reinhold U, Kukel S, Goeden B, Neumann U, Kreysel HW: Functional characterization of skin-infiltrating lymphocytes in atopic dermatitis. Clin Exp Immunol 86:444-448, 1991
31. Shenker BJ, Kushner ME, Tsai CC: Inhibition of fibroblast proliferation by aciono-bacillus actinomycetemcomitans. Infect Immun 38:986-992, 1982
32. Tsai M, Shih LS, Newlands GF, et al: The rat c-kit ligand, stem cell factor, induces the development of connective tissue-type and mucosal mast cells in vivo. Analysis by anatomical distribution, histochemistry, and protease phenotype. J Exp Med 174:125-131, 1991
33. Valent P, Spanblöchl E, Sperr WR, et al: Induction of differentiation of human mast cells from bone marrow and peripheral blood mononuclear cells by recombinant human stem cell factor/kit-ligand in long-term culture. Blood 80:2237-2245, 1992
34. Welker P, Grabbe J, Gibbs B, Zuberbier T, Henz BM: Human mast cells produce and differentially express both soluble and membrane-bound stem cell factor. Scand J Immunol 49:495-500, 1999
35. Weller EM, Poot M, Hoehn H: Induction of replicative senescence by 5-azacytidine: Fundamental cell kinetic differences between human diploid fibroblasts and NIH-3T3 cells. Cell Prolif 26:45-54, 1993